77 related articles for article (PubMed ID: 7773151)
1. The role of decreased retinoblastoma protein expression in acute myelomonocytic and monoblastic leukemias.
Weide R; Parviz B; Pflüger KH; Köppler H; Wörmann B; Zühlsdorf M; Havemann K
Leuk Lymphoma; 1995 Mar; 17(1-2):135-7. PubMed ID: 7773151
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of the human retinoblastoma gene in monocytic leukaemias.
Weide R; Parviz B; Pflüger KH; Havemann K
Br J Haematol; 1993 Mar; 83(3):428-32. PubMed ID: 8485048
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
4. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
[TBL] [Abstract][Full Text] [Related]
5. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
6. [CD34+ antigen expression relating to prognosis in acute myeloid leukemia].
Li L; Wang R; Zhong D; Wen BZ; Abulaiti D; Lin ZQ; Jia M; Hao JP; Chen R; Guo XH; Wang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):812-4. PubMed ID: 16277848
[TBL] [Abstract][Full Text] [Related]
7. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
Sorensen PH; Chen CS; Smith FO; Arthur DC; Domer PH; Bernstein ID; Korsmeyer SJ; Hammond GD; Kersey JH
J Clin Invest; 1994 Jan; 93(1):429-37. PubMed ID: 8282816
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation.
van der Schoot CE; Jansen P; Poorter M; Wester MR; von dem Borne AE; Aarden LA; van Oers RH
Blood; 1989 Nov; 74(6):2081-7. PubMed ID: 2478222
[TBL] [Abstract][Full Text] [Related]
9. IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells.
Vinante F; Rigo A; Vincenzi C; Ricetti MM; Marrocchella R; Chilosi M; Cassatella MA; Bonazzi L; Pizzolo G
Leukemia; 1993 Oct; 7(10):1552-6. PubMed ID: 8412317
[TBL] [Abstract][Full Text] [Related]
10. Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias.
Caceres-Cortes JR; Alvarado-Moreno JA; Waga K; Rangel-Corona R; Monroy-Garcia A; Rocha-Zavaleta L; Urdiales-Ramos J; Weiss-Steider B; Haman A; Hugo P; Brousseau R; Hoang T
Cancer Res; 2001 Aug; 61(16):6281-9. PubMed ID: 11507083
[TBL] [Abstract][Full Text] [Related]
11. Interferon production by peripheral blood leukocytes of patients with acute myeloid leukemia.
Kandefer-Szerszeń M; Dmoszyńska A; Borowska L; Adamczyk-Cioch M; Hus M; Hus I; Roliński J
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):119-22. PubMed ID: 8915515
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.
Metelitsa LS; Weinberg KI; Emanuel PD; Seeger RC
Leukemia; 2003 Jun; 17(6):1068-77. PubMed ID: 12764370
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas.
Weide R; Tiemann M; Pflüger KH; Köppler H; Parvizl B; Wacker HH; Kreipe HH; Havemann K; Parwaresch MR
Leukemia; 1994 Jan; 8(1):97-101. PubMed ID: 8289506
[TBL] [Abstract][Full Text] [Related]
14. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.
Ysebaert L; Chicanne G; Demur C; De Toni F; Prade-Houdellier N; Ruidavets JB; Mansat-De Mas V; Rigal-Huguet F; Laurent G; Payrastre B; Manenti S; Racaud-Sultan C
Leukemia; 2006 Jul; 20(7):1211-6. PubMed ID: 16688229
[TBL] [Abstract][Full Text] [Related]
15. [A study on interleukin-2 receptor genes in acute myeloid leukemia cells].
Yang Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):288-92. PubMed ID: 10684036
[TBL] [Abstract][Full Text] [Related]
16. The effect of monocytic involvement of hyperaldolasaemia in patients with acute myelogenous leukaemia.
Hassan HT; Zyada LE; Rees JK; Ragab MH
Haematologia (Budap); 1990; 23(2):73-7. PubMed ID: 2272537
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical detection of factor XIII A--subunit in acute leukemia.
Invernizzi R; De Fazio P; Iannone AM; Zambelli LM; Rastaldi MP; Ippoliti G; Ascari E
Leuk Res; 1992 Aug; 16(8):829-36. PubMed ID: 1382173
[TBL] [Abstract][Full Text] [Related]
18. Expression of the retinoblastoma tumor suppressor gene (RB-1) in acute leukemia.
Sauerbrey A; Stammler G; Zintl F; Volm M
Leuk Lymphoma; 1998 Jan; 28(3-4):275-83. PubMed ID: 9517499
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-2 in patients with monocytic leukemia.
Scherrer A; Kruithof EK; Grob JP
Leukemia; 1991 Jun; 5(6):479-86. PubMed ID: 2056772
[TBL] [Abstract][Full Text] [Related]
20. Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation.
Dobrowolska H; Gill KZ; Serban G; Ivan E; Li Q; Qiao P; Suciu-Foca N; Savage D; Alobeid B; Bhagat G; Colovai AI
Cytometry B Clin Cytom; 2013; 84(1):21-9. PubMed ID: 23027709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
